DUSTIN RILEY: Open Payments
NPI 1598027963 · MINDEN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 39 payments from 11 companies in 2025. Trend: 2023 $662 · 2024 $579 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $189 |
| ABBVIE INC. | 7 | $143 |
| PFIZER INC. | 6 | $121 |
| Amgen Inc. | 5 | $90 |
| Exact Sciences Corporation | 4 | $67 |
| Novo Nordisk Inc | 2 | $30 |
| Lilly USA, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: NURTEC ODT, OTEZLA, BREZTRI, Cologuard Collection Kit, VRAYLAR, UBRELVY, PREVNAR 20, Ozempic.
Industry payments across NV — which companies pay providers there.
